The American Journal of Drug and Alcohol Abuse · 2017 · 47 citations · 11 references
MedicinePediatricsPsychiatryAddiction PsychiatryAdolescent HealthSubstance Use DisordersAddictionDrug DependenceMedication-assisted TreatmentOpioid ManagementOpioid TherapyOpioid Use DisorderAdolescent Opioid Use DisorderBarriersDrug Use By AdolescentsMedication-assisted Treatment For PainMedication-assisted Treatment PrescribingMedication-assisted Treatment ReferralOpioid Use Disorder Treatment AccessTreatment-related Harms
The prevalence of risky opioid use, opioid use disorder, and related harms continue to rise among youth (adolescents and young adults age 15-25) in North America. With an increasing number of opioid overdoses, there remain significant barriers to care for youth with opioid use disorder, and there is an urgent need to expand evidence-based care for treatment of opioid use disorder among this population. Based on the extensive literature on treatment of opioid use disorder among adults, medicated-assisted treatment is likely to be an important or even essential component of treatment of opioid use disorder for most youth. In this article, we outline the current dilemmas and questions regarding the use of medication-assisted treatment among youth with opioid use disorder and propose some potential solutions based on the current evidence.
11
Extended vs Short-term Buprenorphine-Naloxone for Treatment of Opioid-Addicted Youth
George Woody, Sabrina Poole, Geetha Subramaniam et al. · JAMA · 2008 · 358 citations · Full text